goetzpartners advised Chequers Capital

Fortlane Partners advised

Exyte on the

of TTP Group

goetzpartners advised

goetzpartners advised the

of Central Glass Germany GmbH

goetzpartners advised

EvoTec SE on the

of Rigenerand Srl

230,000,00 €

goetzpartners advised

Otto Group on the

of Medgate Holding & Better Doc

goetzpartners advised

Pharmaron on its

of Aesica Pharmaceuticals from Recipharm

goetzpartners advised

doctari group on the

of Planerio GmbH

goetzpartners advised

Pharmaron on its

of Allergan Biologics from AbbVie

goetzpartners advised

EUSA Pharma on the

of the global commercialization rights to the oncology product ISQETTE

goetzpartners advised

Penta Investment on the

of Lloyds Pharma

goetzpartners advised

Penta Investment on the

of Gehe Pharma

goetzpartners advised

TÜV Süd on the

of MSOURCE from its founder, Dr. Adriaan Hart de Ruijter